RELATED CONTENT
August 11, 2020 — SyntheticMR announced its imaging software SyMRI is compatible with additional scanners from Siemens ...
August 11, 2020 
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI Neuro product packages together with magnetic resonance imaging (MRI) systems from Siemens Healthineers.
June 14, 2019 
April 19, 2017 — REMyDI (Rapid Estimation of Myelin for Diagnostic Imaging), first introduced by SyntheticMR AB at the ...
April 19, 2017 
SyntheticMR AB introduced REMyDI for automatic quantification of myelin volume in the brain at the 2016 annual meeting of the Radiological Society of North America (RSNA) in November. Easy quantification of myelin allows clinicians to follow myelination in the developing brain and monitor myelin degeneration in patients with demyelinating and neurodegenerative disorders. REMyDI is a feature of the SyMRI post-processing software from SyntheticMR.
January 06, 2017 
SyntheticMR and The University of Texas MD Anderson Cancer Center have signed a research agreement to study SyMRI to characterize brain tumors.
January 20, 2016 
Linköping University Hospital in Sweden has installed SyMRI Neuro from SyntheticMR in order to improve the follow-up of patients with multiple sclerosis (MS).
September 02, 2015 
Cincinnati Children’s Hospital Medical Center (CCHMC) has evaluated synthetic magnetic resonance imaging (MRI) on pediatric cases to study and clinically validate its use on children. Results from the first part of the evaluation, which used SyMRI software, shows the synthetic images are diagnostically satisfactory in comparison with conventional sequences.
June 02, 2015